中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [75]
广州生物医药与健康研... [4]
大连化学物理研究所 [3]
合肥物质科学研究院 [3]
上海生物化学与细胞生... [2]
昆明动物研究所 [2]
更多
采集方式
OAI收割 [92]
iSwitch采集 [2]
内容类型
期刊论文 [90]
学位论文 [3]
会议论文 [1]
发表日期
2024 [2]
2023 [6]
2022 [16]
2021 [11]
2020 [9]
2019 [8]
更多
学科主题
Pharmacolo... [2]
Biochemist... [1]
Genetics &... [1]
Oncology [1]
Research &... [1]
化学工程 [1]
更多
筛选
浏览/检索结果:
共94条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 265, 页码: 14
作者:
Chen, Xuetao
;
Wu, Tingting
;
Du, Zhiyan
;
Kang, Wenjing
;
Xu, Rujun
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2024/02/27
BET
BD1
Bromodomain
Brain-permeable
Multiple sclerosis
Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 4, 页码: 2466-2486
作者:
Chang, Qi
;
Li, Jiayi
;
Deng, Yue
;
Zhou, Ruilin
;
Wang, Bingwei
  |  
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2024/03/25
Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 262, 页码: 18
作者:
Zhang, Jingyu
;
Duan, Haiting
;
Gui, Renzhao
;
Wu, Mingfei
;
Shen, Liteng
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2023/12/19
Acute myeloid leukemia
Bromodomain-containing protein 9
Proteolysis-targeting chimera
Orally bioavailable
Docking
Discovery of 1H-Imidazo[4,5-b]pyridine Derivatives as Potent and Selective BET Inhibitors for the Management of Neuropathic Pain
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 13, 页码: 8725-8744
作者:
Chen, Xuetao
;
Cao, Danyan
;
Liu, Chihong
;
Meng, Fanying
;
Zhang, Zijian
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2023/10/17
Nanovesicles loaded with a TGF-& beta; receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2023, 卷号: 14, 期号: 1, 页码: 18
作者:
Zhou, Mengxue
;
Wang, Jiaxin
;
Pan, Jiaxing
;
Wang, Hui
;
Huang, Lujia
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2023/10/17
Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell lines
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 254, 页码: 17
作者:
Yan, Ziqin
;
Lyu, Xilin
;
Lin, Dongze
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2023/10/17
Cyclization strategy leads to highly potent Bromodomain and extra-terminal (BET) Bromodomain inhibitors for the treatment of acute liver injury
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 247, 页码: 13
作者:
Chen, Chao
;
Lu, Tian
;
Chen, Panyu
;
Li, Zizhou
;
Yang, Yaxi
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2023/04/10
BET Bromodomains
Acute liver injury
Anti-inflammatory activity
Inhibitors
Tetracyclic compounds
Design, synthesis, and biological evaluation of BRD4 degraders
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 卷号: 78, 页码: 12
作者:
Ding, Mengyuan
;
Shao, Yingying
;
Sun, Danwen
;
Meng, Suorina
;
Zang, Yi
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2023/04/10
PROTAC
BRD4 degradation
Leukemia
Multiple myeloma
Pulmonary fibrosis
Loss of VOPP1 Contributes to BET Inhibitor Acquired Resistance in Non-Small Cell Lung Cancer Cells
期刊论文
OAI收割
MOLECULAR CANCER RESEARCH, 2022, 卷号: 20, 期号: 12, 页码: 1785-1798
作者:
Sun, Lin
;
Wu, Qian
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2024/03/21
Proteomic characterization of post-translational modifications in drug discovery
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 页码: 18
作者:
Zhai, Lin-hui
;
Chen, Kai-feng
;
Hao, Bing-bing
;
Tan, Min-jia
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2023/04/10
proteomics
protein post-translational modification
drug target
off-target
drug mechanism
precision medicine